Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G. Systemic Lupus Erythematosus. Nat Rev Dis Primers. 2016;2(1):16039. https://doi.org/10.1038/nrdp.2016.39.

Article  PubMed  Google Scholar 

Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81–96. https://doi.org/10.7326/AITC202006020.

Article  PubMed  Google Scholar 

Aw YTV, Whiley PJ, Lorenzo AM, Lea-Henry T, Shanmuganandam S, Stanley M, Babu SN, Athanasopoulos V, Cappello J, Ellyard JI, et al. Immunophenotyping identifies distinct Cellular signatures for systemic Lupus Erythematosus and Lupus Nephritis. Rheumatol Autoimmun. 2023;3(1):15–25. https://doi.org/10.1002/rai2.12060.

Article  CAS  Google Scholar 

Shi X, Wang Z, Tang R, Chen WP. Injury and Death: New insights into Lupus Nephritis Pathogenesis and Therapy. Rheumatol Autoimmun. 2023;3(4):193–204. https://doi.org/10.1002/rai2.12103.

Article  CAS  Google Scholar 

Zhu JT. Helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb Perspect Biol. 2018;10(10):a030338. https://doi.org/10.1101/cshperspect.a030338.

Article  PubMed  PubMed Central  Google Scholar 

Cheng Q, Chen X, Xu J, Chen M, Zhang P, Wu H, Du Y. lncRNA X-inactive‐specific transcript is a potential biomarker related to changes in CD4 + T cell levels in systemic Lupus Erythematosus. Rheumatol Autoimmun. 2022;2(3):159–74. https://doi.org/10.1002/rai2.12048.

Article  CAS  Google Scholar 

Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, Kyttaris VC, Juang Y-T, Tsokos GC. Expanded Double Negative T Cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761–6. https://doi.org/10.4049/jimmunol.181.12.8761.

Article  PubMed  Google Scholar 

Garcia S. Role of semaphorins in Immunopathologies and Rheumatic diseases. IJMS. 2019;20(2):374. https://doi.org/10.3390/ijms20020374.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nishide M, Kumanogoh A. The role of Semaphorins in Immune responses and Autoimmune Rheumatic diseases. Nat Rev Rheumatol. 2018;14(1):19–31. https://doi.org/10.1038/nrrheum.2017.201.

Article  PubMed  CAS  Google Scholar 

Koda T, Namba A, Kinoshita M, Nakatsuji Y, Sugimoto T, Sakakibara K, Tada S, Shimizu M, Yamashita K, Takata K, et al. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the Effector Phase. J Neuroinflammation. 2020;17(1):82. https://doi.org/10.1186/s12974-020-01757-w.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goldberg JL, Vargas ME, Wang JT, Mandemakers W, Oster SF, Sretavan DW, Barres BA. An Oligodendrocyte Lineage-Specific Semaphorin, Sema5A, inhibits Axon Growth by Retinal Ganglion cells. J Neurosci. 2004;24(21):4989–99. https://doi.org/10.1523/JNEUROSCI.4390-03.2004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, Giordano S, Comoglio PM, Tamagnone L. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 2004;5(7):710–4. https://doi.org/10.1038/sj.embor.7400189.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Matsuoka RL, Chivatakarn O, Badea TC, Samuels IS, Cahill H, Katayama K-I, Kumar SR, Suto F, Chédotal A, Peachey NS, et al. Class 5 transmembrane Semaphorins Control Selective mammalian retinal lamination and function. Neuron. 2011;71(3):460–73. https://doi.org/10.1016/j.neuron.2011.06.009.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lyu M, Li Y, Hao Y, Sun T, Liu W, Lyu C, Fu R, Li H, Xue F, Liu X, et al. Elevated semaphorin 5A correlated with Th1 polarization in patients with chronic Immune Thrombocytopenia. Thromb Res. 2015;136(5):859–64. https://doi.org/10.1016/j.thromres.2015.07.032.

Article  PubMed  CAS  Google Scholar 

Liu Y, Wang S, Guo Q, Li Y, Qin J, Zhao N, Li Y, Shan Z, Teng W. Elevated semaphorin 5A in patients with Hashimoto’s Thyroiditis: a case-control study. Endocr Connect. 2017;6(8):659–66. https://doi.org/10.1530/EC-17-0132.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lobna M, Nasren E, Adi S, Jacob B, Maria G-AA, Marcus M, Zahava V. The expression of IL-17, in chronic spontaneous urticaria is linked to Semaphorin5A. Biomolecules. 2021;11(3):373. https://doi.org/10.3390/biom11030373.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, et al. Elevated semaphorin5A in systemic Lupus Erythematosus is in Association with Disease Activity and Lupus Nephritis. Clin Exp Immunol. 2017;188(2):234–42. https://doi.org/10.1111/cei.12924.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hochberg MC. Updating the American College of Rheumatology Revised Criteria for the classification of systemic Lupus Erythematosus. Arthritis Rheum. 1997;40(9):1725. https://doi.org/10.1002/art.1780400928.

Article  PubMed  CAS  Google Scholar 

Gras C, Eiz-Vesper B, Jaimes Y, Immenschuh S, Jacobs R, Witte T, Blasczyk R, Figueiredo C. Secreted semaphorin 5A activates Immune Effector cells and is a biomarker for rheumatoid arthritis: secreted semaphorin 5A in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(6):1461–71. https://doi.org/10.1002/art.38425.

Article  PubMed  CAS  Google Scholar 

Chen M-Z, Su L-Y, Ko P-H, Hsu M-H, Chuang L-L, Chen L-H, Lu T-P, Chuang EY, Chow L-P, Tsai M-H, et al. Extracellular domain of semaphorin 5A serves a tumor–suppressing role by activating Interferon Signaling pathways in Lung Adenocarcinoma cells. Int J Oncol. 2022;60(2):21. https://doi.org/10.3892/ijo.2022.5311.

Article  PubMed  CAS  Google Scholar 

Cheng Q, Chen M, Liu M, Chen X, Zhu L, Xu J, Xue J, Wu H, Du Y. Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis. Cell Death Dis. 2022;13(7):608. https://doi.org/10.1038/s41419-022-05065-4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qin Y, Jin J, Zhang J, Wang H, Liu L, Zhang Y, Ling S, Hu J, Li N, Wang J, et al. A fully human monoclonal antibody targeting semaphorin 5A alleviates the progression of rheumatoid arthritis. Biomed Pharmacother. 2023;168:115666. https://doi.org/10.1016/j.biopha.2023.115666.

Article  PubMed  CAS  Google Scholar 

Paquissi FC, Abensur H. The Th17/IL-17 Axis and kidney diseases, with Focus on Lupus Nephritis. Front Med (Lausanne). 2021;8:654912. https://doi.org/10.3389/fmed.2021.654912.

Article  PubMed  Google Scholar 

Krohn S, Nies JF, Kapffer S, Schmidt T, Riedel J-H, Kaffke A, Peters A, Borchers A, Steinmetz OM, Krebs CF, et al. IL-17 C/IL-17 receptor E signaling in CD4 + T cells promotes TH17 cell-driven glomerular inflammation. J Am Soc Nephrol. 2018;29(4):1210–22. https://doi.org/10.1681/ASN.2017090949.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Petrovic-Djergovic D, Popovic M, Chittiprol S, Cortado H, Ransom RF, Partida-Sánchez S. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate Puromycin Aminonucleoside Nephrosis. Clin Exp Immunol. 2015;180(2):305–15. https://doi.org/10.1111/cei.12579.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Panzer U, Steinmetz OM, Paust H-J, Meyer-Schwesinger C, Peters A, Turner J-E, Zahner G, Heymann F, Kurts C, Hopfer H, et al. Chemokine receptor CXCR3 Mediates T Cell Recruitment and Tissue Injury in Nephrotoxic Nephritis in mice. J Am Soc Nephrol. 2007;18(7):2071–84. https://doi.org/10.1681/ASN.2006111237.

Article  PubMed  CAS  Google Scholar